Welcome to our dedicated page for Galapagos Nv SEC filings (Ticker: GLPG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Galapagos NV (GLPG) SEC filings page on Stock Titan brings together the company’s U.S. regulatory disclosures as a foreign private issuer listed on Nasdaq. Galapagos files current reports on Form 6-K, which typically furnish press releases and other information to the U.S. Securities and Exchange Commission. These reports often incorporate company announcements by reference into Galapagos’ registration statements on Form S-8, reflecting updates relevant to its equity compensation plans.
Through these filings, investors can follow how Galapagos communicates material information about its biotechnology business in oncology, immunology, inflammation, fibrosis, and other indications. The 6-Ks referenced in the record indicate that Galapagos issues press releases on topics such as clinical programs, collaborations, and corporate developments, and then submits those releases to the SEC. The filings also identify Galapagos NV as having its principal executive office in Mechelen, Belgium and clarify whether the company files under Form 20-F or Form 40-F reporting frameworks.
On Stock Titan, each new GLPG filing is captured as it becomes available from EDGAR, and AI-powered tools summarize the key points of lengthy documents. Users can quickly see what a particular 6-K press release covers without reading every page, and can navigate to the underlying exhibits for full details. Over time, this page forms a chronological record of Galapagos’ SEC reporting, helping investors review how the company’s pipeline, collaborations, and strategic decisions have been communicated to the market.
For anyone researching GLPG, this filings archive offers a structured way to examine regulatory disclosures alongside AI-generated highlights, making it easier to understand the context and content of Galapagos NV’s ongoing SEC reporting.
Galapagos NV (ticker: GLPG) filed a Form 6-K on 20 June 2025. The submission is primarily administrative in nature. It:
- Announces that a press release dated 18 June 2025 is furnished as Exhibit 99.1.
- States that the information in the report—excluding specific physician quotations in the exhibit—is incorporated by reference into multiple outstanding Form S-8 registration statements.
- Contains no financial statements, earnings metrics, or details on material transactions.
- Is signed by Company Secretary Annelies Denecker.